Vitalité Health Network logo
Imipenem+Cilastatin
Imipenem+Cilastatin

Imipenem+Cilastatin

Zone 6 - Acadie-Bathurst: Gram Negative

% of Isolates Susceptible

Acinetobacter species
100% n = 16
​

Escherichia coli
100% n = 2990
​

Klebsiella oxytoca
100% n = 86
​

Klebsiella pneumoniae
100% n = 407
​

Citrobacter freundii
98% n = 49
​

Resistance may develop during therapy if treated with cephalosporins or beta-lactam/beta-lactamase inhibitors, even if susceptible in vitro - see additional information

Pseudomonas aeruginosa
94% n = 253
​

Klebsiella aerogenes
59% n = 33
​

Resistance may develop during therapy if treated with cephalosporins or beta-lactam/beta-lactamase inhibitors, even if susceptible in vitro - see additional information

Providencia species
48% n = 10
​

Resistance may develop during therapy if treated with cephalosporins or beta-lactam/beta-lactamase inhibitors, even if susceptible in vitro - see additional information

Proteus mirabilis
12% n = 218
​

Serratia marcescens
0% n = 33
​

Resistance may develop during therapy if treated with cephalosporins or beta-lactam/beta-lactamase inhibitors, even if susceptible in vitro - see additional information